Table 1.
Baseline characteristics of peritoneal dialysis patients (n = 70).
| Variables | Mean | SD |
|---|---|---|
| Age (years) | 56.4 | ±13.4 |
| PD vintage (months) | 2.1 | ±1.5 |
| Gender, Male (n, %) | 35 | 50.0% |
| Diabetes mellitus (n, %) | 33 | 47.1% |
| ACEi/ARB (n, %) | 7 | 10.0% |
| Statin (n, %) | 30 | 42.9% |
| Laboratory measurements | ||
| hemoglobin(g/dL) | 10.4 | ±1.5 |
| albumin (g/dL) | 3.6 | ±0.4 |
| fasting glucose(mg/dl) | 106 | 93-198 |
| PET measurements | ||
| Category | ||
| high transport | 14 | 20.3% |
| high average transport | 23 | 33.3% |
| low average transport | 22 | 31.9% |
| low transport | 10 | 14.5% |
| Total KtV | 2.1 | ±0.5 |
| Residual Renal Ccr (ml/min/1.73m2) | 34.9 | 14.4-53.6 |
| Total Ccr (ml/min/1.73m2) | 73.3 | 56.8-86.3 |
| nPCR(g/day) | 1.1 | ±0.3 |
Paired test p-value is estimated using paired t-test.
PD, peritoneal dialysis; ACEi, angiotensin converting enzyme inhibitor; ARB, angiotensin receptor blockade; VEGF, vascular endothelial growth factor; PAI-1, plasminogen activator inhibitor-1; MMP2, matrix metalloproteinases 2; D/P Cr, dialysate: plasma creatinine.